Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | PRSS12 | P56730 | 2/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | APLNR | P35414 | 3/20 | 0.41 |
| ▸ | PRCP | P42785 | 4/20 | 0.39 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.39 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.39 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | B3GNT2 | Q9NY97 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5100614 | 1.00 | L3MBTL1 (0.48) | L3MBTL1PRSS12TDP1KDM4ELMNA | |
| SCHEMBL5096849 | 0.90 | L3MBTL1 (0.50) | L3MBTL1PRSS12TDP1KDM4ELMNA | |
| SCHEMBL5096847 | 0.90 | L3MBTL1 (0.50) | L3MBTL1PRSS12TDP1KDM4ELMNA | |
| SCHEMBL5101081 | 0.86 | L3MBTL1 (0.47) | L3MBTL1PRSS12TDP1KDM4ELMNA | |
| SCHEMBL5101086 | 0.86 | L3MBTL1 (0.47) | L3MBTL1PRSS12TDP1KDM4ELMNA | |
| SCHEMBL5097196 | 0.86 | TDP1 (0.46) | L3MBTL1PRSS12TDP1KDM4ELMNA | |
| SCHEMBL5100187 | 0.86 | TDP1 (0.44) | L3MBTL1PRSS12TDP1KDM4ELMNA | |
| SCHEMBL14277108 | 0.86 | TDP1 (0.46) | L3MBTL1PRSS12TDP1KDM4ELMNA | |
| SCHEMBL6526024 | 0.83 | L3MBTL1 (0.55) | L3MBTL1TDP1KDM4ELMNAALDH1A1 | |
| SCHEMBL6533170 | 0.83 | L3MBTL1 (0.55) | L3MBTL1TDP1KDM4ELMNAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080132496-A1 | CARBOXYLIC ACID AMIDES, THE PREPARATION THEREOF, AND THEIR USE AS PHARMACEUTICAL COMPOSITIONS | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) | 2008-06-05 | — | — | US | disclosed |
| US-7326791-B2 | Carboxylic acid amides, the preparation thereof, and their use as pharmaceutical compositions | BOEHRINGER INGELHEIM PHARMA GMBH & CO., KG (DE) | 2008-02-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080132496-A1 | CARBOXYLIC ACID AMIDES, THE PREPARATION THEREOF, AND THEIR USE AS PHARMACEUTICAL COMPOSITIONS | F12, F11, F2 | L3MBTL1 4590/4885PRSS12 2712/4885TDP1 1525/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.